These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 16003319)
21. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649 [TBL] [Abstract][Full Text] [Related]
22. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X; Kandasamy K; Srivastava RK Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723 [TBL] [Abstract][Full Text] [Related]
23. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639 [TBL] [Abstract][Full Text] [Related]
24. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis. Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911 [TBL] [Abstract][Full Text] [Related]
25. Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. Petak I; Douglas L; Tillman DM; Vernes R; Houghton JA Clin Cancer Res; 2000 Oct; 6(10):4119-27. PubMed ID: 11051265 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L; Fang B Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937 [TBL] [Abstract][Full Text] [Related]
27. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells. Matsuzaki H; Schmied BM; Ulrich A; Standop J; Schneider MB; Batra SK; Picha KS; Pour PM Clin Cancer Res; 2001 Feb; 7(2):407-14. PubMed ID: 11234897 [TBL] [Abstract][Full Text] [Related]
29. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Van Geelen CM; de Vries EG; de Jong S Drug Resist Updat; 2004 Dec; 7(6):345-58. PubMed ID: 15790545 [TBL] [Abstract][Full Text] [Related]
30. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Kang J; Bu J; Hao Y; Chen F Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917 [TBL] [Abstract][Full Text] [Related]
31. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL. Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726 [TBL] [Abstract][Full Text] [Related]
32. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K; Douglas L; Delaney AB; Houghton JA Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213 [TBL] [Abstract][Full Text] [Related]
33. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma. Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273 [TBL] [Abstract][Full Text] [Related]
34. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284 [TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Tang X; Sun YJ; Half E; Kuo MT; Sinicrope F Cancer Res; 2002 Sep; 62(17):4903-8. PubMed ID: 12208739 [TBL] [Abstract][Full Text] [Related]
37. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
38. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Hernandez A; Thomas R; Smith F; Sandberg J; Kim S; Chung DH; Evers BM Surgery; 2001 Aug; 130(2):265-72. PubMed ID: 11490359 [TBL] [Abstract][Full Text] [Related]
39. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
40. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Knight MJ; Riffkin CD; Muscat AM; Ashley DM; Hawkins CJ Oncogene; 2001 Sep; 20(41):5789-98. PubMed ID: 11593384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]